Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Kamataki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Kamataki, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 48, Issue of November 28, 1997 pp. 30025-30031

Inhibition of the Transcription of CYP1A1 Gene by the Upstream Stimulatory Factor 1 in Rabbits
COMPETITIVE BINDING OF USF1 WITH AhR·Arnt COMPLEX*

(Received for publication, June 6, 1997, and in revised form, August 12, 1997)

Yoshiki Takahashi , Kazuo Nakayama , Susumu Itoh Dagger , Yoshiaki Fujii-Kuriyama § and Tetsuya Kamataki

From the Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University, N12W6, Kita-ku, Sapporo, Hokkaido 060, Japan

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

A xenobiotic-responsive element (XRE)-binding factor(s) other than the AhR·Arnt complex was found to inhibit the transcription of CYP1A1 gene in the liver from adult rabbits, known to be nonresponsive to CYP1A1 inducers. The constitutive factor(s) in liver nuclear extracts bound to the core sequence of XRE. The binding was eliminated by the presence of an excess amount of the AhR·Arnt complex synthesized in vitro. To identify the constitutive factor(s), a sequence similar to rabbit XRE was sought. It was found that the sequence of rabbit XRE overlapped with that of the upstream stimulatory factor 1 (USF1)-binding site in the mouse metallothionein I promoter. In fact, a super shift assay using a specific antibody against human USF1 indicated that USF1 was capable of binding to rabbit XRE. Additionally, the AhR·Arnt-mediated activation of XRE-TK/Luc reporter gene in RK13 cells was blocked by the transfection with a USF1 expression vector with the amounts of the expression vector transfected. These results indicate that the XRE of the rabbit CYP1A1 gene is recognized by the basic helix-loop-helix proteins to regulate the expression of CYP1A1 in both an agonistic (AhR·Arnt) and an antagonistic (USF1) manner.


INTRODUCTION

CYP1A1 is the microsomal enzyme responsible for the bioactivation of carcinogenic compounds such as benzo[a]pyrene (1) and is known to be induced by halogenated aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)1 and polycyclic aromatic hydrocarbons including MC (2, 3). However, the induction of CYP1A1 by MC occurs only in neonatal but not in adult rabbits (4-7). To date, this mechanism seen in rabbits has not been clarified despite its significance in toxicology.

The activation of CYP1A1 gene by aryl hydrocarbons is mediated by a soluble protein designated as AhR (8). Prior to the binding with such an inducer, AhR exists in the cytoplasm as part of a complex that has a molecular mass of about 280 kDa. This complex is comprised of AhR, two molecules of the 90-kDa heat shock protein (Hsp90), and possibly other proteins (9-12). After binding with a ligand, AhR dissociates from the above complex and translocates to the nucleus where it heterodimerizes with Arnt (13, 14). The heterodimer AhR·Arnt complex binds to several copies of short sequences, termed XREs, located within the 5'-flanking region of CYP1A1 gene to stimulate the synthesis of CYP1A1 protein and several other proteins involved in xenobiotic metabolism (15-18). Thus, the induction of CYP1A1 is regulated exclusively at the transcriptional level (19, 20).

AhR and Arnt proteins have two domains necessary for the TCDD-induced activation of CYP1A1 gene. One of the two domains is the Per-Arnt-Sim region composed of approximately 300 amino acids that mediates the ligand binding and interaction with Hsp90. This region is also found in the Drosophila regulatory proteins Per and Sim (21) and the mammalian hypoxia-inducible factor 1alpha (22). The other is a bHLH motif essential to the DNA binding and the dimerization of AhR and Arnt toward their amino termini (23, 24).

The bHLH motif has been seen in common in a number of transcriptional factors. Most transcriptional factors such as Max, USF1, MyoD, and E47 contain bHLH motif and bind as dimers to the specific DNA sequence (CACGTG), termed E-box (25-28). Recently, it has been reported that Arnt constitutively binds as a homodimer to the E-box motif of AdMLP (29, 30). On the other hand, the AhR·Arnt heterodimer recognizes an asymmetrical XRE sequence that only partially resembles the E-box. The consensus sequence of XRE has been identified as 5'-(T/G)NGCGTG(A/C)(G/C)(A/T)-3' (31-33). Four core nucleotides (5'-CGTG-3') within XRE are absolutely required for the binding with AhR·Arnt heterodimer. Arnt binds to the thymidine in the 5'-CGTG-3' core identical to an E-box half site (GTG), whereas AhR binds to 5' proximal to the 5'-CGTG-3' core in the XRE (34). In the present study, we found USF1 to be an additional factor capable of binding to the rabbit XRE to inhibit the interaction of the AhR·Arnt complex with XRE in rabbits.


MATERIALS AND METHODS

Isolation of the 5'-Flanking Region of Rabbit CYP1A1 Gene

To isolate the 5'-flanking region of rabbit CYP1A1 gene (35), a gene library prepared from the rabbit DNA cleaved by EcoRI and cloned into lambda ZAPII vector (Stratagene, La Jolla, CA) was screened with a 32P-labeled CYP1A1 cDNA as a probe (36). By screening about 1.1 × 105 plaques, we obtained a genomic clone (pBK4.5k) containing the 5'-flanking region of rabbit CYP1A1 gene and mapped for further studies.

Construction of Reporter and Expression Plasmids

Fusion genes with various external deletions were constructed as follows. The pBK4.5k was treated with exonuclease III after cleavage with SacI and BamHI. The digested plasmids were treated with T4 DNA ligase and then introduced into Escherichia coli TG1 to yield intermediate plasmids. These intermediate plasmids were cleaved with KpnI and HindIII to shorten them and to obtain the various lengths of 5'-flanking sequences. The fragments were inserted into the unique KpnI-HindIII site of the basic vector 2 (Stratagene).

A cDNA fragment for human USF1 (37) was obtained by reverse transcription-polymerase chain reaction from human placenta RNA. The entire coding regions of rabbit AhR (7), rabbit Arnt (7), and human USF1 cDNAs (37) were ligated into a mammalian expression vector pUC-SRalpha (38). The resultant expression plasmids, designated AhR-SRalpha , Arnt-SRalpha , and USF-SRalpha , were used for the transfection. To ascertain the contribution of USF1 in rabbit kidney RK13 cells, reporter plasmids XRE-TK/Luc and TK/Luc were constructed. The double-stranded XRE was subcloned into the basic vector 2 by a blunt end ligation. The basal TK promoter was then inserted into the NheI-HindIII site of the plasmid. The copy number and the direction of the oligonucleotides inserted into the reporter plasmids were confirmed by sequence analysis (39).

Preparation of Nuclear Extracts

Nuclear extracts were prepared from the livers of nontreated rabbits (New Zealand White, male) at 0-4 °C as described by Schibler et al. (40), except for 1% aprotinin (Sigma) and 0.1 mM PMSF (Wako, Osaka, Japan) in an initial homogenization buffer. Nuclear extracts were dialyzed against 25 mM Hepes (pH 7.9) containing 40 mM KCl, 0.5 mM PMSF, 0.1 mM EDTA, 1 mM dithiothreitol, and 10% glycerol twice for 2 h at 4 °C. Subsequently, the extracts were snap-frozen in 0.05-ml aliquots at 5-10 mg of protein/ml and stored in liquid nitrogen.

Nuclear extracts from RK13 cells were prepared according to the method of Dignam et al. (41). Twice the cell volumes of buffer A (10 mM Hepes (pH 7.9) containinng 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol, and 0.5 mM PMSF) were added into a tube containing cells. The cell suspension was kept on ice for 10 min. Then the cells were homogenized (20-30 strokes) and centrifuged. The cells were washed once with the buffer A and were resuspended with a pellet volume of a dialysis buffer (20 mM Hepes (pH 7.9) containing 100 mM KCl, 12.5 mM MgCl2, 0.1 mM EDTA, 17% glycerol, 2 mM dithiothreitol, and 0.5 mM PMSF), followed by the addition of the same volume of the dialysis buffer containing 1.26 M NaCl. The solution was centrifuged at 200,000 × g for 30 min. The supernatant was dialyzed toward the dialysis buffer. The solution was used as the RK13 nuclear extract.

Gel Shift Assay

Gel shift assay was performed with 10 µl of a reaction mixture containing 25 mM Hepes (pH 7.9), 4% Ficoll, 40 mM KCl, 0.5 mM dithiothreitol, 0.1 mM EGTA, 1 mM MgCl2, 0.5 µg of poly(dI-dC), 1 µg of carrier DNA, 5% glycerol, 5-10 µg of nuclear extracts, and a 32P-labeled probe DNA (5 fmol). The mixture was incubated at 25 °C for 1 h. Oligonucleotide primers used as probes are as follows: XRE3, 5'-TCCCCCCAGTTCGCGTGACTGCGCCGGGA-3' and 3'-AGGGGGGTCAAGCGCACTGACGCGGCCCT-5'; mutant XRE3, 5'-TCCCCCCAGTTCGATTGACTGCGCCGGGA-3' and 3'-AGGGGGGTCAAGCTAACTGACGCGGCCCT-5'; XRE4, 5'-CGCCCAGGAGTTGCGTGAGAAGGGCTTGGA-3' and 3'-GCGGGTCCTCAACGCACTCTTCCCGAACCT-5'; XRE5, 5'-GAGTCCCTGCTCGCGTGAGAAGCTCAGCGACC-3' and 3'-CTCAGGGACGAGCGCACTCTTCGAGTCGCTGG-5'; AdMLP, 5'-GATCCGTAGGCCACGTGACCGGG-3' and 3'-CTAGGCATCCGGTGCACTGGCCC-5'.

In Vitro Transcription and Translation

In vitro transcription and translation assays were carried out using a rabbit reticulocyte lysate system (Toyoinki, Tokyo, Japan). Briefly, 1 µg of pBAhR/KS (7) or pBArnt/KS (7) was added to a reaction mixture (50 µl) containing 50% of a rabbit reticulocyte lysate, 20 µM complete amino acid mixture, 40 units of a ribonuclease inhibitor, and 20 units of T7 RNA polymerase. The reaction mixture was incubated at 30 °C for 90 min. AhR and Arnt were labeled by the addition of [35S]methionine to this system. The products were subjected to SDS-polyacrylamide gel electrophoresis for molecular weight analysis. A complementary pair of synthetic oligonucleotides containing the core sequence of XRE was annealed and end-labeled with [gamma -32P]dATP. A nonspecific competitor, poly(dI-dC) (4.5 ng), was mixed with rabbit AhR and Arnt proteins, expressed in vitro, and incubated for 20 min at 25 °C. The radiolabeled probe (1 × 105 cpm) was then added and incubated for 20 min at 25 °C, followed by a nondenaturing gel electrophoresis and autoradiography.

Kd Values

The Kd values of a XRE-binding factor(s) were calculated from the results of a gel shift assay with a fixed amount of nuclear extracts and the various concentrations of the radiolabeled XRE3. After gel electrophoresis and autoradiography, radiolabeled bands corresponding to the bound and the free DNAs were excised. The resultant radioactivity was measured by a LSC-300 liquid scintillation counter (Aloka, Tokyo, Japan).

Antibodies

Antibodies against human AhR and Arnt proteins were prepared as described previously (30). Antibodies to human USF1 were purchased from Santa Cruz Biotechnology, Inc. (Santa, Cruz, CA). The super shift assay was performed using these antibodies as follows. After incubation of probe DNAs with a rabbit nuclear extract as described above, antibodies were added to the reaction mixtures and incubated for 1 h at 4 °C. The products were then analyzed by a gel shift assay.

Cell Culture and Transient Transfection

Rabbit kidney RK13 cells were grown in a minimal essential medium containing fetal calf serum (10%) and nonessential amino acids (42). Reporter and expression constructs were introduced into the cultured cells by a modification of the calcium phosphate coprecipitation procedure (43). After exposure for 16 h, the DNA-containing culture medium was removed. The cells were washed with a minimal essential medium and then exposed to a culture medium with either 1 µM MC or the equivalent volume of Me2SO (0.1% (v/v) at final concentration as a control). After another 38 h, the cells were washed with phosphate-buffered saline (0.01 M sodium phosphate, 0.15 M NaCl) and then lysed. Insoluble materials were removed by centrifugation. A luciferase activity was determined using Lumat LB9501 luminometer (Berthold, Tokyo, Japan). beta -Galactosidase activity was determined as described (43). Each luciferase activity was corrected by beta -galactosidase activity.


RESULTS

Analysis of Sequences in an Upstream Region Responsible for the Induction of Rabbit CYP1A1 in RK13 Cells

To identify possible regions responsible for the MC-induced expression of rabbit CYP1A1 gene, 5' deletion mutants were constructed as shown in Fig. 1A. These plasmids were transfected into rabbit kidney RK13 cells to show the inducibility of CYP1A1 by some inducers (data not shown). The cells were then exposed to MC. The maximal MC-induced activity was seen in the cells transfected with Luc1.6. The activity decreased with progressive deletions starting from -1.6 kb of rabbit CYP1A1 gene. The luciferase activity was significantly decreased by the deletion of the sequences between nucleotides -1.06 and -0.95 kb, -0.95 and -0.83 kb, and -0.68 and -0.45 kb from the transcriptional start sites. These results indicate that at least three regions containing essential XREs are responsible for the induction of rabbit CYP1A1 gene. Deletions to -1.28 kb resulted in an approximately 55% decrease in a constitutive expression, whereas further deletions to -0.18 kb decreased to about 5%. Comparing the sequences of possible XREs in the 5'-flanking region of rabbit CYP1A1 gene up to -1.4 kb with the consensus sequence (Fig. 1B) reported so far, XRE3, XRE4, and XRE5 were found to be identical with the reported consensus sequence (31-33). However, other XREs possessed the replacement of some nucleotides from the consensus sequence. To analyze the specificity of AhR·Arnt to bind to the XREs, a competition analysis was carried out (Fig. 1C). The specific binding of AhR·Arnt disappeared when a 150-fold molar excess of an unlabeled probe (XRE3, XRE4, or XRE5) was added. Thus, we focused on the XREs that possibly regulate the CYP1A1 induction by MC in RK13 cells.


Fig. 1. Regulatory DNA elements in the 5'-flanking region of rabbit CYP1A1 gene. A, structure and transcriptional activity of 5' deletion mutants in the 5'-flanking region of CYP1A1 gene. The construction of deletion mutants is described under "Materials and Methods." The numbers given to deletion plasmids indicate the 5' ends of the 5'-flanking sequence of rabbit CYP1A1 gene counted negatively from the transcriptional start site. The XRE most distant from the mRNA start site was defined as XRE1. The extent of induction by MC is shown as the ratio of the induced to the uninduced activity. The position of the XRE most distant from XRE6 is shown by a vertical arrow. All values represent the means ± S.D. with the number of independent experiments shown in parentheses. The data are expressed as a percentage of the basal activity obtained with Luc4.5. B, alignment of possible XREs found in the 5'-flanking region of rabbit CYP1A1 gene. The sequence of the rabbit XRE was compared with that of consensus sequences identified in the CYP1A1 gene reported so far (31-33). The numbers given to XREs indicate the position of the nucleotide counted negatively from the transcriptional initiation site. C, competition analysis with various XREs. A synthetic XRE4 was used as a labeled probe. Rabbit AhR and Arnt proteins produced by in vitro translation were incubated in the presence of 1 µM MC, followed by gel shift assay as described under "Materials and Methods." The arrow indicates the AhR·Arnt·XRE4 complex. A competitor DNA was added at 75- or 150-fold molar excess of the probe XRE4 DNA. The elimination of the shifted band by the addition of a 150-fold molar excess of XRE3, XRE4, or XRE5 demonstrates the specificity of the complex. Mutant XRE used as a competitor is as follows: XRE4 mu, 5'-CGCCCAGGAGTTGATTGAGAAGGGCTTGGA-3' and 3'-GCGGGTCCTCAACTAACTCTTCCCGAACCT-5'. To prove the specificity of AhR·Arnt heterodimer, a 150-fold molar excess of XRE4 mutant was added.

[View Larger Version of this Image (42K GIF file)]


Constitutive Binding to Functional XRE

We found a constitutive factor(s) in rabbit liver nuclear extracts that bound to XRE3 and XRE5. Thus, the amounts of the constitutive factor(s) present in the nuclear extracts from neonatal livers were compared with those from adult livers (Fig. 2). The binding of a liver-specific transcriptional factor HNF4 (44) was monitored as a control. The amount of the constitutive factor(s) bound to XRE3 and XRE5 was greater in the nuclear extracts from adult rabbit livers than neonatal rabbit livers. No shifted bands were observed when the nuclear extracts from neonatal and adult livers were added to XRE4 used as a probe.


Fig. 2. Comparison of the amounts of constitutive factor(s) in neonatal and adult rabbit livers that bound to XRE. Liver nuclear extracts from nontreated rabbits (New Zealand White, male) were prepared according to the method of Schibler et al. (40). A 32P-labeled double-stranded XRE3, XRE4, or XRE5 was incubated with 10 µg of nuclear extracts from neonatal or adult rabbit livers at 25 °C for 1 h as described under "Materials and Methods." The arrow indicates the major constitutive factor(s) bound to rabbit XREs. As a control experiment, the binding activity of HNF4 was determined in neonatal and adult livers.

[View Larger Version of this Image (44K GIF file)]


Competition between the Constitutive Factor(s) and the AhR·Arnt Complex to Bind to the XRE

As a first step to prove our idea that the unknown XRE-binding factor(s) in the nuclear extracts from adult rabbit livers bound to XRE to compete with the AhR·Arnt complex, we examined the possibility that the constitutive factor(s) recognized the core sequence of XRE. As shown in Fig. 3A, the factor(s) did not bind to a XRE possessing a mutation, indicating that the core sequence of XRE was specifically recognized by the constitutive factor(s). Additionally, the shifted band disappeared when a 300-fold molar excess of a nucleotide with a consensus sequence (CANNTG) was added, supporting the idea that this constitutive factor(s) belongs to the bHLH family. These results indicate that the factor(s) bound to bHLH sequence modulates CYP1A1 induction in adult rabbit livers by competition with the AhR·Arnt complex to bind to XRE. To test this possibility, we examined whether or not the competition occurred between the factor(s) and AhR·Arnt heterodimer to bind to the XRE. When nuclear extracts from adult rabbit livers were absent, the AhR·Arnt complex clearly bound to XRE3 to show a shifted band (Fig. 3B). The amount of the AhR·Arnt heterodimer to bind to XRE3 was decreased by the addition of the constitutive factor(s). Addition of a large amount of the AhR·Arnt complex was needed to obtain an efficient binding to XRE3 in the presence of the factor(s) (Fig. 3B). These results suggest that the constitutive factor(s) in adult rabbit livers regulates CYP1A1 induction by competing with the AhR·Arnt complex.


Fig. 3. Constitutive factor(s) recognizing the core sequence of XRE3. A, specificity of a constitutive binding factor(s) to bind to XRE3. A 32P-labeled double-stranded XRE3 was incubated with 10 µg of nuclear extracts from adult rabbit livers at 25 °C for 1 h as described. Mutant XRE3 as described under "Materials and Methods" was used as a probe to demonstrate the specificity of the constitutive complex. Competitor DNAs were also used at 100- (XRE3), 200-, or 300-fold (bHLH consensus (25-28)) molar excess of the probe DNA. B, the competitive binding of a constitutive factor(s) with AhR·Arnt complex. The DNA binding of the AhR·Arnt complex and the constitutive factor(s) were examined by a competitive binding assay in which various amounts (1-7 µl) of AhR·Arnt complex synthesized in vitro were added. Rabbit AhR and Arnt proteins were incubated in the presence of 1 µM MC, followed by gel shift assay as described under "Materials and Methods."

[View Larger Version of this Image (43K GIF file)]


The Affinities of the AhR·Arnt Complex and the Constitutive Factor(s) to Bind to XRE3

The affinities of the AhR·Arnt complex and the constitutive factor(s) to bind to DNA were calculated by saturation binding assays in which a fixed amount of the factor(s) was added and by the binding assay by titration with the increasing amounts of radiolabeled XRE3 (Fig. 4). The data were plotted as the amount of the bound XRE3 versus the total amount of XRE3. The dissociation constants were calculated from Scatchard plots of the formation of the complex versus the amounts of free XRE3. The results showed that Kd values for the AhR·Arnt complex and the constitutive factor(s) were 2.6 and 1.8 nM, respectively, indicating that the affinities for XRE3 were similar.


Fig. 4. Kinetic analysis of a constitutive factor(s) (A) and AhR·Arnt complex to XRE3 (B). The Kd values were calculated by Scatchard plots. After gel electrophoresis and autoradiography, the radiolabeled bands corresponding to the bound and free XREs were excised, and the radioactivity was measured by the scintillation counter. The left panels show the autographic images of the gel shift assay. The middle panels are saturation curves in which the amount of bound XRE3 versus total XRE3 was plotted. The right panels show Scatchard plots.

[View Larger Version of this Image (21K GIF file)]


Gel Shift Assay Using Antibodies

To prove that the constitutive factor(s) did not contain AhR and Arnt, a gel shift assay using antibodies to human AhR and human Arnt (Fig. 5) was performed. To remove AhR and Arnt from the nuclear extracts, antibodies to human AhR or Arnt were added to the nuclear extracts from adult rabbit livers. The results showed that a shifted band corresponding to the constitutive factor(s) appeared, indicating that a factor(s) other than the AhR·Arnt complex recognized the core sequence of XRE. The binding of AhR·Arnt heterodimer to XRE disappeared when the antibodies against human AhR were added. Although antibodies to human AhR inhibited the heterodimerization of AhR with Arnt, antibodies to human Arnt did not inhibit the formation of the AhR·Arnt complex (30). Thus, a super shifted band was detected by the presence of the antibodies against human Arnt.


Fig. 5. The constitutive binding factor(s) did not contain the AhR and Arnt. A 32P-labeled double-stranded XRE3 was incubated with 10 µg of nuclear extracts prepared from adult rabbit livers in the absence or the presence of anti-AhR or anti-Arnt antibodies as described under "Materials and Methods." As a control experiment, AhR·Arnt synthesized in vitro was incubated in the absence or the presence of the antibodies.

[View Larger Version of this Image (23K GIF file)]


Similarity of the Recognition Sites of AhR·Arnt Complex and USF1

We found that the sequence of rabbit XRE3 was similar to that of the USF1-binding site (Fig. 6). The USF1-binding site was originally identified as the E-box motif (CACGTG) of AdMLP (45). This site was also found in human growth hormone (46), mouse metallothionein I (47), rat gamma -fibrinogen (48), and Xenopus TFIIIA genes (49), although some nucleotides in the binding site of USF1 identified in a variety of cellular and viral promoters differed from those in the E-box motif (50). It is of particular interest to note that the sequence of rabbit XRE3 is identical to that of the USF1-binding site (CGCGTGAC) in the mouse metallothionein I promoter.


Fig. 6. Alignment of the binding sites for USF1. The sequences are aligned with 8-base pair domain CANNTGAC, which is a consensus binding motif for USF1 (50). The core sequence of XRE3 was identical to that of the USF1-binding site in mouse metallothionein I promoter (47).

[View Larger Version of this Image (24K GIF file)]


Binding of USF1 to XRE3 in the Rabbit CYP1A1 Gene

To determine if USF1 could bind to XRE3, we performed a competition assay using an E-box motif of AdMLP as a competitor. When nuclear extracts from adult rabbit livers were added, the formation of the complex with XRE3 was abolished by the presence of a 50-fold molar excess of the unlabeled AdMLP (Fig. 7A). Super shift bands were detectable with antibodies against USF1, although the amounts of super shift bands varied depending on the probe (Fig. 7B). To further prove the specific binding of USF1 with XRE3, USF1 was expressed in RK13 cells by transfection of the expression plasmid USF-SRalpha into the cells. Nuclear extracts prepared from the cells were applied to a gel shift assay. Consequently, a specific band appeared only when nuclear extracts from USF1-transfected cells were applied. Antibodies against USF1 recognized the super shifted band. This antibody-bound complex exhibited a further retarded mobility in the polyacrylamide gel (Fig. 7C).


Fig. 7. Binding of USF1 to XRE3. A, competition between a constitutive factor(s) and AdMLP to bind to XRE3. A 32P-labeled double-stranded XRE3 fragment was incubated with 10 µg of nuclear extracts from adult rabbit livers in the presence of a 50-, 100-, and 150-fold molar excess amount of AdMLP at 25 °C for 1 h. The arrow indicates the complex of a constitutive factor(s) with XRE3. B, super shift assay using antibodies to USF1. A 32P-labeled double-stranded XRE3 or AdMLP was incubated with nuclear extracts from adult rabbit livers in the absence or the presence of antibody against human USF1 as described under "Materials and Methods." The arrow indicates the super shifted band of USF1. C, binding of human USF1 expressed in RK13 cells to XRE3. Nuclear extracts from RK13 cells transfected with USF1-SRalpha were prepared essentially as described by Dignam et al. (41). A 32P-labeled double-stranded XRE3 was incubated with 10 µg of the nuclear extracts from RK13 cells at 25 °C for 1 h. The specificity of the binding of USF1 was determined by super shift assay as described under "Materials and Methods." The arrow indicates the complex of human USF1 with XRE3.

[View Larger Version of this Image (38K GIF file)]


Suppression of the MC-induced Expression of CYP1A1 by USF1

To determine the functional consequences of the interaction of USF1 with XRE3 of rabbit CYP1A1 gene, the expression plasmid carrying USF1 was cotransfected to RK13 cells with the expression vectors for AhR and Arnt in addition to the XRE-TK/Luc or TK/Luc. Relative to pUC-SRalpha -transfected or nontransfected cells, the transfection of AhR- and Arnt-SRalpha together with XRE-TK/Luc resulted in a 2-fold increase in basal expression in the absence of MC. USF1 inhibited the transactivation of XRE-TK/Luc reporter gene by the AhR·Arnt complex and MC (Fig. 8B). Relative to the maximum induction observed with the absence of USF-SRalpha (16 ± 1-fold), the down-regulation observed with USF-SRalpha (2 µg) (9.5 ± 0.3-fold) and USF-SRalpha (4 µg) (6.1 ± 0.2-fold) was significant with p values all equal to <0.0001 but not with USF-SRalpha (1 µg) (14 ± 1-fold) with p value of >0.05. The increasing amounts of the USF-SRalpha expression vector did not affect basal expression. However, the transfection of USF-SRalpha (>5 µg) enhanced the basal activity of XRE-TK/Luc gene (data not shown). The co-transfection of RK13 cells with the USF1 expression vector together with Luc 1.28 reporter plasmid inhibited the induction by MC by 39% (data not shown). These results indicate that USF1 depresses the induction of CYP1A1 by MC in rabbit livers by competing XRE3 with the AhR·Arnt complex.


Fig. 8. Inhibition by USF1 of AhR·Arnt-mediated transactivation of XRE3 to express CYP1A1. A, the schematic illustration of reporter plasmids. Reporter plasmids XRE-TK/Luc and TK/Luc were constructed as described under "Materials and Methods." B, co-transfection to assess the contribution of USF1. AhR-SRalpha (3 µg), Arnt-SRalpha (3 µg), USF-SRalpha (0-4 µg), and pUC-SRalpha (3 µg) were co-transfected to RK13 cells in combination with XRE-TK/Luc (2 µg) or TK/Luc (2 µg). An appropriate amount of pUC-SRalpha was added to adjust the total amount of DNA transfected to the cells. The medium was removed 16 h after the initiation of the transcription. The cells were then washed and exposed to a medium supplemented with either dimethyl sulfoxide or 1 µM MC for 38 h. All values represent the means ± S.D. (n = 3). The mean value obtained with XRE-TK/Luc in the absence of USF-SRalpha and in the presence of AhR-SRalpha , Arnt-SRalpha , and MC was defined as 100%.

[View Larger Version of this Image (24K GIF file)]



DISCUSSION

The induction of CYP1A1 by MC occurs only in neonatal and not in adult rabbits, probably resulting in low susceptibility to carcinogens (4-7). However, the mechanism(s) involved in the nonresponsive nature of rabbits to such an inducer in rabbits has not been clarified despite its significance in toxicology. Our hypothesis to account for this phenomenon is that bHLH proteins in addition to the AhR·Arnt complex are capable of recognizing the core sequence of XRE and that a factor(s) that binds to XRE inhibits the induction of CYP1A1 by MC in adult rabbits. To examine this idea, we performed a gel shift assay using nuclear extracts from adult rabbit livers as a competitor to the binding of the AhR·Arnt complex with XRE3 and found a constitutive factor(s) that inhibited the binding as was expected.

Scatchard plots showed that the binding affinity of the factor(s) for XRE3 was similar to that of the AhR·Arnt complex (Fig. 4). In fact, the binding of the AhR·Arnt complex to XRE3 was not observed even after treatment of adult rabbits with MC. Alternatively, the constitutive factor(s) bound to XRE3 (data not shown). Recently, we reported that there was a lesser amount of Arnt mRNA in rabbit livers than in extrahepatic tissues (7). Thus, it is possible that the amount of Arnt limits the amount of the AhR·Arnt complex, leading to the low level of induction of CYP1A1. These results indicate that the interaction of a constitutive factor(s) with XRE3 occurs predominantly in the livers from MC-treated rabbits, accounting for the known fact that the induction by MC does not occur in adult rabbits.

A computer search was performed to find a sequence(s) similar to XRE3 in the rabbit CYP1A1 gene. The sequence of rabbit XRE3 was highly homologous to that of USF1-binding sites (Fig. 6). The presence of the conserved sequences has been reported in AdMLP (45), human growth hormone (46), mouse metallothionein I (47), rat gamma -fibrinogen (48), and Xenopus TFIIIA genes (49). Particularly, the sequences of XRE3 and XRE5 were identical to the USF1-binding site of mouse metallothionein I promoter (CGCGTG) (Fig. 6). The existence of the XRE core sequence (CGCGTG) allowed us to predict that rabbit CYP1A1 gene is regulated in a positive (AhR·Arnt) and a negative (USF1) manner through the overlapped XRE sequence. Interestingly, the portion of XRE sequence identical with that of USF1 sequence was conserved in humans but not in rats and mice known to be highly responsive to aromatic hydrocarbons (34, 51, 52). Unlike the rabbit CYP1A1 gene, the binding site of USF1 was not found in the possible XRE sequences in the 5'-flanking region of rabbit CYP1A2 gene (35). CYP1A2 is known to be induced by TCDD in both neonatal and adult rabbit livers (35).

Our super shift assay indicated that one of the constitutive factor(s) was USF1, a bHLH protein (Fig. 5). However, the E-box motif is reported to be recognized by a number of bHLH proteins such as USF2, Max, MyoD, and E47 (25-28, 53, 54). This suggests that a factor(s) in addition to USF1 also binds to the core sequence of XRE3. In fact, only some of the bands were super shifted by antibodies to USF1 when XRE3 and AdMLP were used as probes. Similar to the binding shown in the present study, the factor(s) constitutively bound to XRE has been found in human keratinocytes (55) and human fibroblasts (56). It has also been reported that an additional XRE-binding factor was detectable only in the presence of TCDD (17). Because these findings were obtained with XREs that did not contain the binding site of USF1 within the core sequence, the constitutive factor (USF1) found in the present study was distinct from the above factors. Recently, it has been reported that AhR2 negatively regulates the MC-induced expression of CYP1A1 gene by blocking the heterodimerization of AhR with Arnt or competing with the AhR·Arnt complex on the same binding site (57). Thus, a factor such as AhR2 may also contribute to the negative regulation of the induction of CYP1A1 in rabbits.

To date, the mechanism responsible for the suppression of the induction of CYP1A1 has been widely discussed. A negative regulatory element has been found in the 5'-flanking region of human CYP1A1 gene (58-61). An unknown factor(s) in HepG2 cells bound to a 21-base pair palindrome in the human CYP1A1 gene, resulting in the negative regulation of the enhancement of the transcription of CYP1A1 gene by TCDD. Because the negative regulatory element was not present in the upstream region of rabbit CYP1A1 gene, the incapability of adult rabbits to induce CYP1A1 must not be caused by the negative regulatory element-binding factor(s).

In the present study, we showed that USF1 bound to XRE3 to compete with the AhR·Arnt complex in the rabbit CYP1A1 gene. Because the sequence of XRE3 in the rabbit, to which USF1 bound, was not present in the 5'-upstream region of rat and mouse CYP1A1 gene, the inhibition of the induction by USF1 may not occur in the rat and mouse. This regulation of CYP1A1 expression may account, at least in part, for the species differences in chemical carcinogenesis and cytotoxicity.


FOOTNOTES

*   This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Present address: Div. of Cellular Physiology, Faculty of Pharmaceutical Sciences, Osaka University, 1-6, Yamadaoka, Suita, Osaka 565, Japan.
§   Present address: Dept. of Chemistry, Faculty of Science, Tohoku University, Sendai 980-77, Japan.
   To whom correspondence should be addressed. Tel. and Fax: 81-11-706-4978; E-mail: kamataki{at}pharm.hokudai.ac.jp.
1   The abbreviations used are as follows: TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; MC, 3-methylcholanthrene; AhR, aryl hydrocarbon receptor; Arnt, Ah receptor nuclear translocator; XRE, xenobiotic-responsive element; bHLH, basic helix-loop-helix; USF1, upstream stimulatory factor 1; AdMLP, adenovirus major late promoter; TK, thymidine kinase; PMSF, phenylmethanesulfonyl fluoride; kb, kilobase(s).

REFERENCES

  1. Guengerich, F. P. (1988) Cancer Res. 48, 2946-2954 [Free Full Text]
  2. Poland, A., and Knutoson, J. C. (1982) Annu. Rev. Pharmacol. Toxicol. 22, 517-554 [CrossRef][Medline] [Order article via Infotrieve]
  3. Hankinson, O. (1995) Annu. Rev. Pharmacol. Toxicol. 35, 307-340 [CrossRef][Medline] [Order article via Infotrieve]
  4. Kahl, G. F., Friederich, D. E., Bigelow, S. W., Okey, A. B., and Nebert, D. W. (1980) Dev. Pharmacol. Ther. 1, 137-162 [Medline] [Order article via Infotrieve]
  5. Alvares, A. P., Ueng, T.-H., and Eiseman, J. L. (1982) Life Sci. 30, 747-751 [CrossRef][Medline] [Order article via Infotrieve]
  6. Atlas, S. A., Boobis, A. R., Felton, J. S., Thorgeirsson, S. S., and Nebert, D. W. (1977) J. Biol. Chem. 252, 4712-4721 [Free Full Text]
  7. Takahashi, Y., Nakayama, K., Shimojima, T., Itoh, S., and Kamataki, T. (1996) Eur. J. Biochem. 242, 512-518 [Medline] [Order article via Infotrieve]
  8. Whitlock, J. P., Jr. (1990) Annu. Rev. Pharmacol. Toxicol. 30, 251-257 [Medline] [Order article via Infotrieve]
  9. Gonzalez, F. J., Liu, S.-Y., and Yano, M. (1993) Pharmacogenetics 3, 51-57 [CrossRef][Medline] [Order article via Infotrieve]
  10. Perdew, G. H. (1988) J. Biol. Chem. 263, 13802-13805 [Abstract/Free Full Text]
  11. Denis, M., Cuthill, S., Wilkstorm, A. C., Poellinger, L., and Gustafsson, J. K. (1988) Biochem. Biophys. Res. Commun. 155, 801-807 [CrossRef][Medline] [Order article via Infotrieve]
  12. Chen, H.-S., and Perdew, G. H. (1994) J. Biol. Chem. 269, 27554-27558 [Abstract/Free Full Text]
  13. Swanson, H. I., and Bradfield, C. A. (1993) Pharmacogenetics 3, 213-230 [Medline] [Order article via Infotrieve]
  14. Hord, N. G., and Perdew, G. H. (1994) Mol. Pharmacol. 46, 618-626 [Abstract]
  15. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992) Science 256, 1193-1195 [Abstract/Free Full Text]
  16. Whitelaw, M. L., Gottlicher, M., Gustafsson, J. A., and Poellinger, L. (1993) EMBO J. 12, 4169-4179 [Medline] [Order article via Infotrieve]
  17. Probst, M. R., Reisz-Porszasz, S., Agbunag, R. V., Ong, M. S., and Hankinson, O. (1993) Mol. Pharmacol. 44, 511-518 [Abstract]
  18. Pollenz, R. S., Sattler, C. A., and Poland, A. (1994) Mol. Pharmacol. 45, 428-438 [Abstract]
  19. Israel, D. I., and Whitlock, J. P., Jr. (1984) J. Biol. Chem. 259, 5400-5402 [Abstract/Free Full Text]
  20. Gonzalez, F. J., Tukey, R. H., and Nebert, D. W. (1984) Mol. Pharmacol. 26, 117-121 [Abstract]
  21. Nambu, J. R., Lewis, J. O., Wharton, K. A., and Crews, S. T. (1991) Cell 67, 1157-1167 [CrossRef][Medline] [Order article via Infotrieve]
  22. Wang, G. L., Jiang, B., Rue, E. A., and Semenza, G. L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5510-5514 [Abstract/Free Full Text]
  23. Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991) Science 252, 954-958 [Abstract/Free Full Text]
  24. Burbach, K. M., Poland, A., and Bradfield, C. A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 8185-8189 [Abstract/Free Full Text]
  25. Ferré-D'Amaré, A. R., Pendergast, G. C., Ziff, E. B., and Burley, S. K. (1993) Nature 363, 38-45 [CrossRef][Medline] [Order article via Infotrieve]
  26. Ferré-D'Amaré, A. R., Pendergast, G. C., Roeder, R. G., and Burley, S. K. (1994) EMBO J. 13, 180-189 [Medline] [Order article via Infotrieve]
  27. Ma, P. C., Round, M. A., Weintraub, H., and Pabo, C. O. (1994) Cell 77, 451-459 [CrossRef][Medline] [Order article via Infotrieve]
  28. Ellenberger, T., Fass, D., Arnaud, M., and Harrison, S. C. (1994) Genes Dev. 8, 970-980 [Abstract/Free Full Text]
  29. Antonsson, C., Arulampalam, V., Whitelaw, M. L., Petterson, S., and Poellinger, L. (1995) J. Biol. Chem. 270, 13968-13972 [Abstract/Free Full Text]
  30. Sogawa, K., Nakano, R., Kobayashi, A., Kikuchi, Y., Ohe, N., Matsushita, N., and Fujii-Kuriyama, Y. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1936-1940 [Abstract/Free Full Text]
  31. Yao, E. F., and Deninson, M. S. (1992) Biochemistry 31, 5060-5067 [CrossRef][Medline] [Order article via Infotrieve]
  32. Lusska, A., Shen, E., and Whitlock, J. P. (1993) J. Biol. Chem. 268, 6575-6580 [Abstract/Free Full Text]
  33. Swanson, H. I., Chan, W. K., and Bradfield, C. A. (1995) J. Biol. Chem. 270, 26292-26302 [Abstract/Free Full Text]
  34. Bacsi, S. G., Reisz-Porszasz, S, and Hankinson, O. (1995) Mol. Pharmacol. 47, 432-438 [Abstract]
  35. Storm, D. K., Postlind, H., and Tukey, R. H. (1992) Arch. Biochem. Biophys. 294, 707-716 [CrossRef][Medline] [Order article via Infotrieve]
  36. Kagawa, N., Mihara, K., and Sato, R. (1987) J. Biochem. (Tokyo) 101, 1471-1479 [Abstract/Free Full Text]
  37. Gregor, P. D., Sawadogo, M., and Rorder, R. G. (1990) Genes Dev. 4, 1730-1740 [Abstract/Free Full Text]
  38. Kitamura, R., Sato, K., Sawada, M., Itoh, S., Kitada, M., Komori, M., and Kamataki, T. (1992) Arch. Biochem. Biophys. 292, 136-140 [CrossRef][Medline] [Order article via Infotrieve]
  39. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract/Free Full Text]
  40. Schibler, U., Hagenbuchele, O., Wellauer, P. K., and Pittet, A. C. (1983) Cell 33, 501-508 [CrossRef][Medline] [Order article via Infotrieve]
  41. Dignam, J. D., Levovitz, R. M., and Roeder, R. G. (1983) Nucleic Acids Res. 11, 1475-1489 [Abstract/Free Full Text]
  42. Palmer, C. N. A., Hsu, M.-H., Muerhoff, A. S., Griffin, K. J., and Johnson, E. F. (1994) J. Biol. Chem. 269, 18083-18089 [Abstract/Free Full Text]
  43. Sambrook, J., Fritsch, E., F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, pp. 16.30-16.41, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  44. Ramji, D. P., Tadros, M, H., Hardon, E. M., and Cortese, R. (1991) Nucleic Acids Res. 19, 1139-1146 [Abstract/Free Full Text]
  45. Carthew, R. W., Chodosh, L. A., and Sharp, P. A. (1985) Cell 43, 439-448 [CrossRef][Medline] [Order article via Infotrieve]
  46. Peritz, L. N., Fodor, E. J. B., Silversides, D. W., Cattini, P. A., Baxter, J. D., and Eberhardt, N. L. (1988) J. Biol. Chem. 263, 5005-5007 [Abstract/Free Full Text]
  47. Carthew, R. W., Chodosh, L. A., and Sharp, P. A. (1987) Genes Dev. 1, 973-980 [Abstract/Free Full Text]
  48. Chodosh, L. A., Carthew, R. W., Morgan, J. G., Crabtree, G. R., and Sharp, P. A. (1987) Science 238, 684-688 [Abstract/Free Full Text]
  49. Scotto, K. W., Kaulen, H., and Roeder, R. G. (1989) Genes Dev. 3, 651-662 [Abstract/Free Full Text]
  50. Vostrov, A. A., Quitschke, W. W., Vidal, F., Schwarzman, A. L., and Goldgaber, D. (1995) Nucleic Acids Res. 23, 2734-2741 [Abstract/Free Full Text]
  51. Sogawa, K., Fujisawa, S., Yamane, M., and Fujii-Kuriyama, Y. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 8044-8048 [Abstract/Free Full Text]
  52. Denison, M. S., Fisher, J. M., and Whitlock, J. P., Jr. (1988) J. Biol. Chem. 263, 17221-17224 [Abstract/Free Full Text]
  53. Sirito, M., Lin, Q., Maity, T., and Sawadogo, M. (1994) Nucleic Acids Res. 22, 427-433 [Abstract/Free Full Text]
  54. Viollet, B., Lefrancois-Martinez, A.-M., Henrion, A., Kahn, A., Raymondjean, M., and Martinez, A. (1996) J. Biol. Chem. 271, 1405-1415 [Abstract/Free Full Text]
  55. Corton, J. C. (1996) Toxicol. Lett. 85, 67-75 [CrossRef][Medline] [Order article via Infotrieve]
  56. Gradin, K., Wilhelmsson, A., Poellinger, L., and Berghard, A. (1993) J. Biol. Chem. 268, 4061-4068 [Abstract/Free Full Text]
  57. Mimura, J., Ema, M., Sogawa, K., and Fujii, Y. (1996) Abstr. Jpn. Biochem. Soc. 68, 1302
  58. Boucher, P. D., and Hines, R, N. (1995) Carcinogenesis 16, 383-392 [Abstract/Free Full Text]
  59. Boucher, P. D., Ruch, R. J., and Hines, R, N. (1993) J. Biol. Chem. 268, 17384-17391 [Abstract/Free Full Text]
  60. Sterling, K. M., Weaver, J., Ho, K. I., Xu, L. C., and Bresnick, E. (1993) Mol. Pharmacol. 44, 560-568 [Abstract]
  61. Bhat, R., Weaver, J. A., Sterling, K. M., and Bresnick, E. (1996) Int. J. Biochem. Cell. Biol. 28, 217-227 [CrossRef][Medline] [Order article via Infotrieve]

Volume 272, Number 48, Issue of November 28, 1997 pp. 30025-30031
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
H. Utsunomiya, Y.-H. Cheng, Z. Lin, S. Reierstad, P. Yin, E. Attar, Q. Xue, G. Imir, S. Thung, E. Trukhacheva, et al.
Upstream Stimulatory Factor-2 Regulates Steroidogenic Factor-1 Expression in Endometriosis
Mol. Endocrinol., April 1, 2008; 22(4): 904 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Y. Dimova and T. Kietzmann
Cell Type-dependent Regulation of the Hypoxia-responsive Plasminogen Activator Inhibitor-1 Gene by Upstream Stimulatory Factor-2
J. Biol. Chem., February 3, 2006; 281(5): 2999 - 3005.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Jiang and C. R. Mendelson
O2 Enhancement of Human Trophoblast Differentiation and hCYP19 (Aromatase) Gene Expression Are Mediated by Proteasomal Degradation of USF1 and USF2
Mol. Cell. Biol., October 15, 2005; 25(20): 8824 - 8833.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. V. Sun, D. R. Boverhof, L. D. Burgoon, M. R. Fielden, and T. R. Zacharewski
Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences
Nucleic Acids Res., August 24, 2004; 32(15): 4512 - 4523.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. B. Hough and J. Piatigorsky
Preferential Transcription of Rabbit Aldh1a1 in the Cornea: Implication of Hypoxia-Related Pathways
Mol. Cell. Biol., February 1, 2004; 24(3): 1324 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Jiang and C. R. Mendelson
USF1 and USF2 Mediate Inhibition of Human Trophoblast Differentiation and CYP19 Gene Expression by Mash-2 and Hypoxia
Mol. Cell. Biol., September 1, 2003; 23(17): 6117 - 6128.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
X.-P. Yang, L. A. Freeman, C. L. Knapper, M. J. A. Amar, A. Remaley, H. B. Brewer Jr., and S. Santamarina-Fojo
The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene
J. Lipid Res., February 1, 2002; 43(2): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Pan, T. A. Black, Q. Shi, C. A. Jones, N. Petrovic, J. Loudon, C. Kane, C. D. Sigmund, and K. W. Gross
Critical Roles of a Cyclic AMP Responsive Element and an E-box in Regulation of Mouse Renin Gene Expression
J. Biol. Chem., November 30, 2001; 276(49): 45530 - 45538.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Handschin, M. Podvinec, R. Looser, R. Amherd, and U. A. Meyer
Multiple Enhancer Units Mediate Drug Induction of CYP2H1 by Xenobiotic-Sensing Orphan Nuclear Receptor Chicken Xenobiotic Receptor
Mol. Pharmacol., October 1, 2001; 60(4): 681 - 689.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Samoylenko, U. Roth, K. Jungermann, and T. Kietzmann
The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site
Blood, May 1, 2001; 97(9): 2657 - 2666.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Kingsley-Kallesen, D. Kelly, and A. Rizzino
Transcriptional Regulation of the Transforming Growth Factor-beta 2 Promoter by cAMP-responsive Element-binding Protein (CREB) and Activating Transcription Factor-1 (ATF-1) Is Modulated by Protein Kinases and the Coactivators p300 and CREB-binding Protein
J. Biol. Chem., November 26, 1999; 274(48): 34020 - 34028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-H. Chen and K. S. Ramos
A CCAAT/Enhancer-binding Protein Site within Antioxidant/Electrophile Response Element Along with CREB-binding Protein Participate in the Negative Regulation of Rat GST-Ya Gene in Vascular Smooth Muscle Cells
J. Biol. Chem., August 25, 2000; 275(35): 27366 - 27376.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Saito, Y. Takahashi, H. Hashimoto, and T. Kamataki
Novel Transcriptional Regulation of the Human CYP3A7 Gene by Sp1 and Sp3 through Nuclear Factor kappa B-like Element
J. Biol. Chem., October 5, 2001; 276(41): 38010 - 38022.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Kamataki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Kamataki, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement